Loading…
Loading…

| MRK | Merck & Co., Inc. | $126.27 | $311.9B |
| NVO | Novo Nordisk A/S | $49.37 | $219.4B |
| AMGN | Amgen Inc. | $367.38 | $198.3B |
| GILD | Gilead Sciences, Inc. | $130.29 | $161.8B |
| DHR | Danaher Corporation | $179.14 | $126.8B |
| BMY | Bristol-Myers Squibb Company | $60.93 | $124.4B |
| SYK | Stryker Corporation | $314.60 | $120.6B |
| SNY | Sanofi | $43.76 | $105.2B |
| GSK | GSK plc | $50.77 | $101.7B |
| BSX | Boston Scientific Corporation | $43.19 | $64.2B |